FDI equity inflow amount for drugs and pharmaceuticals sector India FY 2015-2023
The drugs and pharmaceuticals sector in India saw a foreign direct investment equity inflow worth over two billion U.S. dollars in the financial year 2023. In the course of the coronavirus (COVID-19) pandemic, Indian pharmaceutical companies are in demand for producing medical equipment, drugs, and vaccination. This explains the sharp increase compared to the previous year and especially compared to the financial year 2019, when investments were worth only 266 million U.S. dollars.